Page last updated: 2024-10-29

ketoconazole and Myelodysplastic Syndromes

ketoconazole has been researched along with Myelodysplastic Syndromes in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denning, DW1
Stepan, DE1
Blume, KG1
Stevens, DA1
Engelhard, D1
Or, R1
Naparstek, E1
Leibovici, V1

Other Studies

2 other studies available for ketoconazole and Myelodysplastic Syndromes

ArticleYear
Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient.
    The Journal of infection, 1992, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Female;

1992
Treatment with itraconazole of widespread tinea corporis due to Trichophyton rubrum in a bone marrow transplant recipient.
    Bone marrow transplantation, 1988, Volume: 3, Issue:5

    Topics: Adult; Bone Marrow Transplantation; Drug Tolerance; Female; Humans; Itraconazole; Ketoconazole; Myel

1988